Non-Alzheimer degenerative dementias

Current Diagnostic Pathology

Volumn 5, Issue 3, 1998, Pages 118-125

  Brett, F M ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009730346     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(98)80020-3     Document Type: Article

References (50)

1. Jellinger K A. Structural basis of dementia in neurodegenerative disorders. J Neural Transm 1996; 47: 1-29.
2. Roman R C, Tatechimi T K, Erkinjuntii T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260.
3. Lowe J, Spillantini M G. Non-Alzheimer degenerative dementias. Brain Pathology 1998; 8: 295-297.
4. Ince P G, Perry E K, Morris C M. Dementia with Lewy Bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathology 1998; 8:299-324.
5. Bowler J V, Munoz D G, Merskey H et al. Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998; 64: 18-24.
6. Rasmusson D X, Brandt J, Steele C et al. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alz Dis Assoc Disord 1996; 10: 180-188.
7. Litvan I, Agid Y, Goetz C, et al. Accuracy in the clinical diagnosis of cortico-basal degeneration: a clinicopathologic study. Neurology 1997; 48: 119-125.
8. Hughes A J. Clinicopathological aspects of Parkinson's disease. Eur Neurol 1997; 38: 13-20.
9. Tison F, Daigues J F, Auriocombe S et al. Dementia in Parkinson's disease. Neurology 1995; 45: 705-708.
10. Jellinger K A. Morphological substrates of dementia in parkinsonism. A critical update. J Neural Transm 1997 (suppl)51:57-82.
11. Churchyard A, Lees A J. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology 1997; 49: 1570-1578.
12. Hansen L, Sakmon D, Galasko D et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990; 40: 1-8.
13. Perry R H, Irving D, Blessed G et al. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sei 1990; 95: 119-139.
14. McKeith I G, Fairbairn A F, Perry R H et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Neurology 1994; 44: 872-877
15. Ala Ta, Yang K H, Sung J H, Frey W H. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopatholoaical study. J Neurol Neurosurg Psychiatr 1997; 62: 16-21.
16. Hansen L A, Galasko D. Lewy body disease. Current Opinion in Neurol and Neurosurg 1992; 5: 889-894.
17. Perry R H, Irving D, Blessed G et al. Clinically and neuropathlogically distinct forms of dementia in the elderly. Lancet 1989; 338: 166.
18. Pollanen M S, Dickson D W, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993; 52: 183-191.
19. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a newdisease? Clin Neuropathol 1984; 3: 185-192.
20. Dickson D W, Ruan D, Crysal H et al. Hippocampa! degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease. Neurology 1991; 41: 1402-1409.
21. Pellise A, Roig C, Barraquer-Bordas Li et al. Abnormal ubiquitinated conical neuriles in patients with diffuse Lewy body disease. Neurosci Lett 1996; 206: 85-88.
22. Samuel W, Galasko D, Masliah E et al. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. Neuropathol Exp Neurol 196; 55: 44-52.
23. Ishikawa A, Takahashi H, Tanaka H et al. Clinical features of familial diffuse Lewy body disease. Eur Neurol 1997; 38: 34-8.
24. De Michèle G, Filla A, Marconi R et al. A genetic study of Parkinson's disease. J Neural Trans 1995; 45(SuppI): 21-25.
25. Saitoh T, Katzman R. Genetic correlations in Lewy body disease. Dementia with Lewy Bodies: New York; Cambridge University Press, 1996.
26. Jackson J, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1996; 91: 127-134.
27. Blass J P, Hayer M D, Nitsch R. A translation of Oto Binswanger's article: The delineation of the general progressive paralyses. Arch Neurol 1991; 48:961-972.
28. Rocca \V A, Hofman A, Brayne C et al. The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. Ann Neurol 1991; 30: 817-824.
29. Drachman D A. New criteria for the diagnosis of vascular dementia: do we know enough yet? Neurology 1993; 43: 243-245.
30. Bennett D A, Gilley D W, Lee S et al. White matter changes: neurobehavioural manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. Dementia 1994; 5: 148-152.
31. Hansen L A, Crain B J. Making the diagnosis of mixed and non-Alzheimer's dementia. Arch Pathol Lab Med 1995; 119: 1023-1031.
32. Plant G T, Revest T, Barnard R O et al. Familial amyloid angiopathy with non-neuritic amyloid plaque formation. Brain 1990; 62: 721-747.
33. Blaudrimont M, Dubas F, Joutel A et al. Autosomal dominant leukoencephalopathy and subcortical ischaemic stroke. A clinicopathological study. Stroke 1993; 24: 122-5.
34. Tomlinson B E, Blessed C, Roth M. Observations on the brains of demented old people. J Neurol Sei 1970; 11: 205-242
35. Dickson D W, Davies P, Bevona C et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (>80 years of age) humans. Acta Neuropathol 1994; 88: 212-221.
36. Scheinberg P. Dementia due to vascular disease: a multifactorial disorder. Stroke 1988; 19: 1291-1299.
37. Meter J S, McClimic K L, Rogers R L et al. Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatr 1988; 51: 1489-1497.
38. Babikian V, Ropper A H. Binswanger's disease: a review. Stroke 1987; 18:2-12.
39. The Lund and the Manchester groups. Consensus on clinical and neuropathological criteria for frontotemporal dementia. J Neurol, Neurosurg, Psychiatry 1994; 57: 416-418.
40. Cooper P N, Jackson M, Lennox G et al. Tau, ubiquitin and a Bcrystallin immunocytochemistry define the principle causes of degenerative frontotemporal dementia. Arch Neurol 1995; 52: 1011-1015.
41. Froelich S, Basun H, Forsell C et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17ql2-21. Am J Med Genet 1997; 74: 380-385.
42. Miller B L, Ikonte C, Ponton M et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 1997; 48: 937-942.
43. Dickson D W. Pick's disease: a modern approach. Brain Pathol 1998; 8: 339-354.
44. Heston L L, White J A, Mastri A R. Pick's disease: clinical genetics and natural history. Arch Gen Psychiatry 1987; 37: 422-124.
45. Hudson A J. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 1981; 104: 217-247.
46. Jackson M, Lennox G, Ward L et al. Frontal dementia with MND inclusions without clinical ALS: a report of eleven cases. Neuropathol Appl Neurobiol 1995; 21: 148-149.
47. Mann D M A. Dementia of frontal type and dementia with subcortical gliosis. Brain Pathol 1998; 8: 325-338.
48. Bindoff L A, Jackson S, Turnbull D M. Mitochondrial and lipid storage disorders of muscle. Disorders of Voluntary muscle; Edingburg: Churchill Livingstone 1994; 717-738.
49. Wiley C A, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994; 36: 673-676.
50. Dalmau J, Graus F, Rosenblum M K et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy. A clinical study of 71 patients. Medicine 1992; 71: 59-72.